Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RETA

Reata Pharmaceuticals (RETA) Stock Price, News & Analysis

Reata Pharmaceuticals logo

About Reata Pharmaceuticals Stock (NASDAQ:RETA)

Advanced Chart

Key Stats

Today's Range
$172.36
$172.36
50-Day Range
$168.70
$172.36
52-Week Range
$21.83
$172.46
Volume
N/A
Average Volume
1.09 million shs
Market Capitalization
$6.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RETA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RETA Stock News Headlines

Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
See More Headlines

RETA Stock Analysis - Frequently Asked Questions

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) issued its earnings results on Monday, November, 8th. The company reported ($1.97) earnings per share for the quarter, beating analysts' consensus estimates of ($2.32) by $0.35. The company's revenue for the quarter was up 428.6% on a year-over-year basis.

Reata Pharmaceuticals (RETA) raised $60 million in an initial public offering on Thursday, May 26th 2016. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and Company and Piper Jaffray acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reata Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Advanced Micro Devices (AMD), Netflix (NFLX), Approach Resources (AREX) and Intel (INTC).

Company Calendar

Last Earnings
11/08/2021
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RETA
Fax
N/A
Employees
321
Year Founded
2002

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$311.90 million
Pretax Margin
-373.40%

Debt

Sales & Book Value

Annual Sales
$23.48 million
Price / Cash Flow
N/A
Book Value
($1.79) per share
Price / Book
-96.29

Miscellaneous

Free Float
27,926,000
Market Cap
$6.58 billion
Optionable
Optionable
Beta
1.42

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:RETA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners